medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2002, Número 1

<< Anterior Siguiente >>

Ann Hepatol 2002; 1 (1)


Zinc sulfate inhibits the enterohepatic cycling of unconjugated bilirubin in subjects with Gilbert’s syndrome

Méndez-Sánchez N, Martínez M, González V, Roldán-Valadez E, Flores MA, Uribe M

Idioma: Ingles.
Referencias bibliográficas: 30
Paginas: 40-43
Archivo PDF: 141.54 Kb.


FRAGMENTO

Sin resumen


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Berk PD, Martin JF, Blaschke TF, Scharschmidt BF, Plotz PH. Unconjugated hyperbilirubinemia: physiologic evaluation and experimental approaches to therapy. Ann Intern Med 1975; 82: 552-570.

  2. Powell LW, Hemingway E, Billing BH, Sherlock S. Idiopathic unconjugated hyperbilirubinemia (Gilbert’s syndrome): a study of 42 families. N Engl J Med 1967; 277: 1108-1112.

  3. Foulk WT, Butt HR, Owen CA, Jr., Whitcomb FF, Mason HL. Constitutional hepatic dysfunction (Gilbert’s disease): its natural history and related syndromes. Medicine (Baltimore) 1959; 38: 25-46.

  4. Bosma PJ, Roy Chowdhury J, Bakker CTM, Gantla S, de Boer A, Oostra BA, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert’s syndrome. N Engl J Med 1995; 333: 1171-1175.

  5. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert’s syndrome. Lancet 1996; 347: 578-581.

  6. Clarke DJ, Moghrabi N, Monaghan G, Cassidy A, Boxer M, Hume R, et al. Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-hemolytic unconjugated hyperbilirubinemias. Clin Chim Acta 1997; 266: 63-74.

  7. Bancroft JD, Kreamer B, Gourley GR. Gilbert’s syndrome accelerates development of neonatal jaundice. J Pediatr 1998; 132: 656-660.

  8. Sampietro M, Lupica L, Perrero L, Romano R, Molteni V, Fiorelli G. TATA-box mutant in the promoter of the uridine diphosphate glucuronosyltransferase gene in Italian patients with Gilbert’s syndrome. Ital J Gastroenterol Hepatol 1998; 30: 194-198.

  9. Black M, Billing BH. Hepatic bilirubin UDP-glucuronyl transferase activity in liver disease and in Gilbert’s syndrome. N Engl J Med 1969; 280: 1266-1271.

  10. Felsher BF, Craig JR, Carpio N. Hepatic bilirubin glucuronidation in Gilbert’s syndrome. J Lab Clin Med 1973; 81: 829-837.

  11. Hauser SC, Gollan J. Bilirubin metabolism and hyperbilirubinemic disorders. In Millward-Sadler GH, Wright R, Arthur MJP. Wright’s liver and biliary disease. 3rd Ed. London, W.B. Saunders Company, 1992; 317-70.

  12. Fevery J, Blanckaert N, Heirwegh KPM, Preaux AM, Berhelot P. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile patients with Gilbert‘s syndrome and Crigler Najjar disease. J Clin Invest 1977; 60: 970-979.

  13. Spivak W, Carey MC. Reverse-phase h.p.l.c. separation, quantification and preparation of bilirubin and its conjugates from native bile. Biochem J 1985; 225: 287-805.

  14. Brink AM, Méndez-Sánchez N, Carey MC. 1996. Bilirubin cycles enterohepatically after ileal resection in the rat. Gastroenterology. 1996; 110: 1945-1957.

  15. Brink MA, Slors JF, Keulemans YC, Mok KS, De Waart DR, Carey MC, et al. Enterohepatic cycling of bilirubin: a putative mechanism for pigment gallstone formation in ileal Crohn’s disease. Gastroenterology 1999; 116: 1420-7.

  16. Dawes LG, Stryler S, Rege R, Nahrwold D. Gallbladder bile composition in Crohn’s disease. Surgical Forum. 1991; 42: 188-189.

  17. Méndez-Sánchez N, Roldán-Valadez E, Flores MA, Cárdenas-Vázquez R, Uribe M. Zinc Salts Precipitate Unconjugated Bilirubin In Vitro and Inhibit Enterohepatic Cycling of Bilirubin in Hamsters. Eur J Clin Invest 2001; 31: 773-80.

  18. Blackaert N. Analysis of bilirubin and bilirubin mono and diconjugates. Determination of their relative amounts in biological samples. Biochem J 1980; 185: 115-128.

  19. Snedecor GW, Cochran WG. Statistical methods. Ames Iowa: The Iowa State University Press 1972.

  20. Moore EW. The role of calcium in the pathogenesis of gallstones: Ca++ electrode studies of model bile salt solutions and other biological systems. Hepatology 1984; 4: 228S-43S.

  21. Sutor DJ, Wilkie LI. Calcium in bile and calcium salts in gallstones. Clin Chem Acta 1977; 79: 119-127.

  22. Dawes LG, Nahrwold DL, Rege RV. Increased total and free ionized calcium in a canine model of pigment gallstones. Surgery 1988; 104: 86-90.

  23. Oyama JH. Hyperbilirubinemia in healthy males or acutely restricted dietary intake receiving parenteral nutrition. Abstract. Am J Clin Nutr 1972; 25: 459.

  24. Gollan JL, Bateman C, Billing BH. Effect of dietary composition on the unconjugated hyperbilirubinemia of Gilbert´s syndrome. Gut 1976; 17: 335-340.

  25. Ostrow JL, Celic L. Bilirubin chemistry, ionization and solubilization by bile salts. Hepatology 1984; 4: 38S-45S.

  26. Stauffer JQ, Steward RJ, Bertrand G. Acquired hyperoxaluria: relationship to dietary calcium content and severity of steatorrhea. Gastroenterology 1974; 66: 783). 122.

  27. Earnest DL. Enteric hyperoxaluria. Adv Intern Med 1979; 24: 407-27.

  28. Caspary WF, Tönissen J, Lankisch PG. “Enteral” Hyperoxaluria. Effect of cholaestryramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man. Acta Hepato-Gastroenterol 1977; 24: 193-200.

  29. Van der Veere CN, Jansen PL, Sinaasappel M, Van der Meer R, Van der Sijs H, Rammeloo JA, Goyens P, Van Nieuwkerk CM, Oude Elferink RP. Oral calcium phosphate: a new therapy for Crigler-Najjar disease? Gastroenterology 1997; 112: 455-62.

  30. Dashti HM, Mathew TC, Jadaon MM, Ashkanani E. Zinc and liver cirrhosis: biochemical and histopathologic assessment. Nutrition 1997; 13: 206-12.




2020     |     www.medigraphic.com